{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:28:38Z","timestamp":1780590518019,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.clinthera.2008.09.004","type":"journal-article","created":{"date-parts":[[2008,10,6]],"date-time":"2008-10-06T04:24:48Z","timestamp":1223267088000},"page":"1681-1684","source":"Crossref","is-referenced-by-count":17,"title":["A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure"],"prefix":"10.1016","volume":"30","author":[{"given":"Dwayne A.","family":"Pierce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shea R.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Reeves-Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.09.004_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1542-4758.2006.00089.x","article-title":"Gabapentin-induced coma in a patient with renal failure","volume":"10","author":"Dogukan","year":"2006","journal-title":"Hemodial Int"},{"key":"10.1016\/j.clinthera.2008.09.004_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1345\/aph.1C242","article-title":"Flumazenil and dialysis for gabapentin-induced coma","volume":"37","author":"Butler","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2008.09.004_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s00415-005-0970-1","article-title":"Gabapentin-induced severe myoclonus in a patient with impaired renal function","volume":"253","author":"Holtkamp","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.clinthera.2008.09.004_bib4","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1592\/phco.2005.25.12.1817","article-title":"Gabapentin-induced neurologic toxicities","volume":"25","author":"Bookwalter","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2008.09.004_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.0013-9580.2005.20804.x","article-title":"Gabapentininduced myoclonus in end-stage renal disease","volume":"46","author":"Zhang","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.clinthera.2008.09.004_bib6","series-title":"Neurontin (gabepentin) [product Information]","year":"2007"},{"key":"10.1016\/j.clinthera.2008.09.004_bib7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2008.09.004_bib8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/j.1552-4604.1995.tb05020.x","article-title":"Disposition of gabapentin in anuric subjects on hemodialysis","volume":"35","author":"Wong","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.09.004_bib9","series-title":"Drug Prescribing in Renal Failure: Dosing Guidelines for Adults","first-page":"67","author":"Aronoff","year":"1999"},{"key":"10.1016\/j.clinthera.2008.09.004_bib10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/00007691-200412000-00008","article-title":"Association between patient age and gabapentin serum concentration-to-dose ratio: A preliminary multivariate analysis","volume":"26","author":"Armijo","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.09.004_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","article-title":"Therapeutic drug monitoring of the newer anitepileptic drugs","volume":"25","author":"Johannessen","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.09.004_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00007691-199912000-00006","article-title":"A case of sustained massive gabapentin overdose without serious side effects","volume":"21","author":"Verma","year":"1999","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.09.004_bib13","first-page":"438","article-title":"Hemodialysis and hemoperfusion for treatment of valproic acid and gabapentin poisoning","volume":"38","author":"Fernandez","year":"1996","journal-title":"Vet Hum Toxicol"},{"key":"10.1016\/j.clinthera.2008.09.004_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/WNL.44.5.982","article-title":"Lack of serious toxicity following gabapentin overdose","volume":"44","author":"Fischer","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2008.09.004_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-91-5-744","article-title":"Furosemideinduced ototoxicity","volume":"91","author":"Gallagher","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2008.09.004_bib16","series-title":"Prinivil (lisinopril) [product information]","year":"2008"},{"key":"10.1016\/j.clinthera.2008.09.004_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0278-5846(82)80162-0","article-title":"Difficulties in assessing adverse drug reactions in clinical trials","volume":"6","author":"Naranjo","year":"1982","journal-title":"Prog Neuropsycho Pharmacol Biol Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180800297X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929180800297X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T03:25:13Z","timestamp":1545708313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929180800297X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S014929180800297X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.09.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}